Human papillomavirus genotype in cervical intraepithelial neoplasia grades 2 and 3 of Taiwanese women

International Journal of Cancer

Volumn 128, Issue 3, 2011, Pages 653-659

  Chao, Angel ^a   Jao, Mei Shan ^a   Huang, Chu Chun ^a   Huang, Huei Jean ^a   Cheng, Hui Hsin ^a   Yang, Jung Erh ^a   Hsueh, Swei ^a   Chen, Tse Ching ^a   Qiu, Jian Tai ^a   Lin, Cheng Tao ^a   Fu, Chang Jui ^a   Chou, Hung Hsueh ^a   Lai, Chyong Huey ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

cervical intraepithelial neoplasia; conization; genotype; HPV

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TAIWAN; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGING; ALPHAPAPILLOMAVIRUS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PRIMERS; DNA, VIRAL; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; POLYMERASE CHAIN REACTION; TAIWAN; UTERINE CERVICAL NEOPLASMS;

EID: 78649867180     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25384     Document Type: Article

References (26)

1. zur Hausen H,. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-8.
2. Kim JJ, Wright TC, Goldie SJ,. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005; 97: 888-95.
3. Paavonen J, Jenkins D, Bosch FX, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter DL, Kitchener HC, Castellsague X, de Carvalho NS, Skinner SR, et al. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007; 369: 2161-70.
4. Ault KA,. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials. Lancet 2007; 369: 1861-8.
5. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-27.
6. Clifford GM, Smith JS, Aguado T, Franceschi S,. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89: 101-5.
7. Clifford GM, Rana RK, Franceschi S, Smith JS, Gough G, Pimenta JM,. Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 1157-64.
8. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM,. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 2007; 121: 621-32.
9. Pretet JL, Jacquard AC, Carcopino X, Monnier-Benoit S, Averous G, Soubeyrand B, Leocmach Y, Mougin C, Riethmuller D,. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer 2008; 122: 424-7.
10. Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE,. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst 2009; 101: 475-87.
11. Liaw KL, Hsing AW, Schiffman MH, You SL, Zhang T, Burk R, Chen CJ,. Human papillomavirus types 52 and 58 are prevalent in cervical cancer from Chinese women. Int J Cancer 1997; 73: 775-6.
12. Huang S, Afonina I, Miller BA, Beckmann AM,. Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women. Int J Cancer 1997; 70: 408-11.
13. Sasagawa T, Basha W, Yamazaki H, Inoue M,. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 45-52.
14. Hwang TS, Jeong JK, Park M, Han HS, Choi HK, Park TS,. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray. Gynecol Oncol 2003; 90: 51-6.
15. An HJ, Cho NH, Lee SY, Kim IH, Lee C, Kim SJ, Mun MS, Kim SH, Jeong JK,. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2003; 97: 1672-80.
16. Lee HS, Kim KM, Kim SM, Choi YD, Nam JH, Park CS, Choi HS,. Human papillomavirus genotyping using HPV DNA chip analysis in Korean women. Int J Gynecol Cancer 2007; 17: 497-501.
17. Chao A, Lin CT, Hsueh S, Chou HH, Chang TC, Chen MY, Lai CH,. Usefulness of human papillomavirus testing in the follow-up of patients with high-grade cervical intraepithelial neoplasia after conization. Am J Obstet Gynecol 2004; 190: 1046-51.
18. Lai CH, Huang HJ, Hsueh S, Chao A, Lin CT, Huang SL, Chao FY, Qiu JT, Hong JH, Chou HH, Chang TC, Chang CJ,. Human papillomavirus genotype in cervical cancer: a population-based study. Int J Cancer 2007; 120: 1999-2006.
19. Lai CH, Chang CJ, Huang HJ, Hsueh S, Chao A, Yang JE, Lin CT, Huang SL, Hong JH, Chou HH, Wu TI, Huang KG, et al. Role of human papillomavirus genotype in prognosis of early-stage cervical cancer undergoing primary surgery. J Clin Oncol 2007; 25: 3628-34.
20. Chao FU, Chao A, Huang CC, Hsueh S, Yang JE, Huang HJ, Wang LC, Lin CT, Fu CJ, Chou HH, Lai CH,. Defining detection threshold and improving analytical proficiency of HPV testing in clinical specimens. Gynecol Oncol 2010; 117: 302-7.
21. Lin CY, Chao A, Yang YC, Chou HH, Ho CM, Lin RW, Chang TC, Chiou JY, Chao FY, Wang KL, Chien TY, Hsueh S, et al. Human papillomavirus typing with a polymerase chain reaction-based genotyping array compared with type-specific PCR. J Clin Virol 2008; 42: 361-7.
22. Bao YP, Li N, Smith JS, Qiao YL,. Human papillomavirus type distribution in women from Asia: a meta-analysis. Int J Gynecol Cancer 2008; 18: 71-9.
23. Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE,. Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res 2009; 69: 3262-6.
24. Castle PE, Jeronimo J, Schiffman M, Herrero R, Rodriguez AC, Bratti MC, Hildesheim A, Wacholder S, Long LR, Neve L, Pfeiffer R, Burk RD,. Age-related changes of the cervix influence human papillomavirus type distribution. Cancer Res 2006; 66: 1218-24.
25. Guo M, Sneige N, Silva EG, Jan YJ, Cogdell DE, Lin E, Luthra R, Zhang W,. Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma. Mod Pathol 2007; 20: 256-66.
26. Kahn JA,. HPV vaccination for the prevention of cervical intraepithelial neoplasia. N Engl J Med 2009; 361: 271-8.